These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 18371028

  • 1. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK, Crawford PC, Kusuhara H, Motokawa K, Gemma T, Watanabe R, Arai S, Bienzle D, Hohdatsu T.
    J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
    [Abstract] [Full Text] [Related]

  • 2. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
    Westman ME, Malik R, Hall E, Sheehy PA, Norris JM.
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
    [Abstract] [Full Text] [Related]

  • 3. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H, Hohdatsu T, Seta T, Nemoto K, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H.
    Vet Microbiol; 2007 Mar 10; 120(3-4):217-25. PubMed ID: 17141431
    [Abstract] [Full Text] [Related]

  • 4. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats.
    Levy JK, Crawford PC, Slater MR.
    J Am Vet Med Assoc; 2004 Nov 15; 225(10):1558-61. PubMed ID: 15568388
    [Abstract] [Full Text] [Related]

  • 5. Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva.
    Westman ME, Malik R, Hall E, Norris JM.
    Comp Immunol Microbiol Infect Dis; 2016 Jun 15; 46():66-72. PubMed ID: 27260813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
    Litster A, Lin JM, Nichols J, Weng HY.
    Vet Microbiol; 2014 Jun 04; 170(3-4):197-205. PubMed ID: 24559863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
    Siebelink CH, Windrich RW, Chu I, Groen J, Weijer K, UytdeHaag FG, Osterhaus AD.
    Dev Biol Stand; 1990 Jun 04; 72():189-96. PubMed ID: 2178115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R, von Beust B, Niederer E, Condrau MA, Fierz W, Aubert A, Ackley CD, Cooper MD, Tompkins MB, Lutz H.
    Vet Immunol Immunopathol; 1992 Dec 04; 35(1-2):199-214. PubMed ID: 1363009
    [Abstract] [Full Text] [Related]

  • 13. New challenges for the diagnosis of feline immunodeficiency virus infection.
    Crawford PC, Levy JK.
    Vet Clin North Am Small Anim Pract; 2007 Mar 04; 37(2):335-50, vii. PubMed ID: 17336678
    [Abstract] [Full Text] [Related]

  • 14. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
    Westman ME, Malik R, Norris JM.
    Aust Vet J; 2019 Mar 04; 97(3):47-55. PubMed ID: 30809813
    [Abstract] [Full Text] [Related]

  • 15. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R, Holznagel E, Aubert A, Ossent P, Reinacher M, Lutz H.
    Vet Immunol Immunopathol; 1995 May 04; 46(1-2):127-37. PubMed ID: 7618252
    [Abstract] [Full Text] [Related]

  • 16. Feline immunodeficiency virus diagnosis after vaccination.
    Andersen PR, Tyrrell P.
    Anim Health Res Rev; 2004 Dec 04; 5(2):327-30. PubMed ID: 15984349
    [Abstract] [Full Text] [Related]

  • 17. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM, Hofmann-Lehmann R, Holznagel E, Cuisinier AM, Wolfensberger C, Duquesne V, Cronier J, Allenspach K, Aubert A, Ossent P, Lutz H.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):275-83. PubMed ID: 9491919
    [Abstract] [Full Text] [Related]

  • 18. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK, Okuda T, Ackley CD, Louie H, Pembroke E, Zochlinski H, Munn RJ, Gardner MB.
    AIDS Res Hum Retroviruses; 1991 Nov 10; 7(11):911-22. PubMed ID: 1662057
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
    Lehmann R, Joller H, Haagmans BL, Lutz H.
    Vet Immunol Immunopathol; 1992 Dec 10; 35(1-2):61-9. PubMed ID: 1337403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.